Best Pharmaceutical Stocks To Watch Now – April 28th

SpringWorks Therapeutics, Eli Lilly and Company, AbbVie, Pfizer, Merck & Co., Inc., Thermo Fisher Scientific, and Honeywell International are the seven Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

SpringWorks Therapeutics (SWTX)

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.

SWTX stock traded up $1.47 during mid-day trading on Monday, hitting $46.19. 70,619,537 shares of the stock were exchanged, compared to its average volume of 1,747,750. The business has a fifty day moving average price of $46.20 and a 200 day moving average price of $40.64. SpringWorks Therapeutics has a 12 month low of $28.21 and a 12 month high of $62.00. The stock has a market capitalization of $3.46 billion, a price-to-earnings ratio of -13.27 and a beta of 0.79.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE LLY traded down $15.99 during trading hours on Monday, reaching $868.55. 2,312,274 shares of the stock traded hands, compared to its average volume of 3,440,548. The company has a market capitalization of $823.53 billion, a P/E ratio of 74.28, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. The company’s 50-day simple moving average is $827.69 and its two-hundred day simple moving average is $817.26. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. Eli Lilly and Company has a 52-week low of $677.09 and a 52-week high of $972.53.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of ABBV traded up $5.20 during mid-day trading on Monday, reaching $191.26. The company’s stock had a trading volume of 5,129,742 shares, compared to its average volume of 6,042,470. The company has a current ratio of 0.66, a quick ratio of 0.55 and a debt-to-equity ratio of 17.94. AbbVie has a 52 week low of $153.58 and a 52 week high of $218.66. The company’s fifty day moving average price is $196.85 and its two-hundred day moving average price is $187.13. The stock has a market cap of $338.33 billion, a PE ratio of 79.64, a P/E/G ratio of 1.62 and a beta of 0.55.

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Pfizer stock traded up $0.06 during mid-day trading on Monday, hitting $22.98. The company’s stock had a trading volume of 31,814,370 shares, compared to its average volume of 40,499,616. The business has a 50 day moving average price of $24.58 and a 200-day moving average price of $25.92. Pfizer has a 12 month low of $20.92 and a 12 month high of $31.54. The stock has a market cap of $130.32 billion, a price-to-earnings ratio of 16.29, a price-to-earnings-growth ratio of 0.64 and a beta of 0.67. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.00 and a quick ratio of 0.73.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of NYSE MRK traded up $0.32 during midday trading on Monday, reaching $83.06. The company had a trading volume of 7,510,811 shares, compared to its average volume of 11,891,935. The stock has a market cap of $209.46 billion, a PE ratio of 12.34, a price-to-earnings-growth ratio of 0.77 and a beta of 0.40. Merck & Co., Inc. has a one year low of $75.93 and a one year high of $134.63. The firm’s fifty day moving average price is $87.05 and its 200-day moving average price is $95.03. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

TMO stock traded down $6.49 during midday trading on Monday, hitting $417.75. The company had a trading volume of 1,267,017 shares, compared to its average volume of 1,742,002. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. Thermo Fisher Scientific has a 52 week low of $409.85 and a 52 week high of $627.88. The stock has a market cap of $157.70 billion, a price-to-earnings ratio of 25.28, a PEG ratio of 2.99 and a beta of 0.86. The stock’s 50 day moving average price is $487.28 and its 200 day moving average price is $526.70.

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

HON traded up $0.09 during trading on Monday, hitting $199.25. 2,327,075 shares of the stock traded hands, compared to its average volume of 4,492,462. The firm has a market capitalization of $128.17 billion, a P/E ratio of 22.88, a price-to-earnings-growth ratio of 2.51 and a beta of 1.01. Honeywell International has a 12-month low of $179.36 and a 12-month high of $242.77. The company has a debt-to-equity ratio of 1.33, a current ratio of 1.31 and a quick ratio of 1.01. The firm has a 50-day moving average of $205.24 and a 200 day moving average of $215.83.